Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

BRIEF-Profound Medical announces agreement with Royal Philips to acquire Sonalleve MR-HIFU Business

Published 2017-06-30, 09:26 a/m
© Reuters.  BRIEF-Profound Medical announces agreement with Royal Philips to acquire Sonalleve MR-HIFU Business
PRN
-

June 30 (Reuters) - Profound Medical Corp PRN.V :

* Profound Medical -Philips to transfer Sonalleve MR-HIFU assets to profound for upfront consideration of 7.4 million common shares of profound at C$1.10/share

* Profound Medical Corp. Announces definitive agreement with royal philips to expand collaboration and acquire sonalleve MR-HIFU business

* Profound Medical Corp - agreement also includes certain earn-out provisions tied to future revenue levels

* Profound Medical - Philips, profound will also expand their non-exclusive strategic sales relationship to include distribution of Sonalleve MR-HIFU

* Profound Medical Corp - if successful, tact is expected to support Profound's application to fda for approval to market TULSA-PRO() in United States

* Profound Medical- TULSA-PRO is ce marked and co is also sponsoring its FDA-registered clinical trial, tact

* Profound Medical Corp - is currently conducting pilot commercial launch of Tulsa-Pro in key european, other ce mark jurisdictions Source text for Eikon: ID:nNRA42klks Further company coverage: PRN.V

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.